−0.0006EUR
−709.00 KEUR
40.56 MEUR
1.35 B
About DMS IMAGING
Sector
Industry
CEO
Frank Hazevoets
Website
Headquarters
Liege
Founded
1997
ISIN
BE0974289218
FIGI
BBG00CSTMNP7
DMS Imaging SA is a clinical stage biopharmaceutical company, which engages in the research and development of immunotherapy treatments for environmental and food allergies. Its products include gp-ASIT+, which is developed for the treatment of allergic rhinitis due to grass pollen; hdm-ASIT+, for the treatment of house dust mite allergy; and pnt-ASIT+for the treatment of peanut allergy. The company was founded by Thierry Legon in 1997 and is headquartered in Liege, Belgium.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ALIMG is 0.0226 EUR — it has increased by 8.65% in the past 24 hours. Watch DMS IMAGING stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange DMS IMAGING stocks are traded under the ticker ALIMG.
ALIMG stock has risen by 7.62% compared to the previous week, the month change is a 25.56% rise, over the last year DMS IMAGING has showed a 55.86% increase.
ALIMG reached its all-time high on Apr 30, 2024 with the price of 0.0370 EUR, and its all-time low was 0.0020 EUR and was reached on Sep 1, 2023. View more price dynamics on ALIMG chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALIMG stock is 11.88% volatile and has beta coefficient of 0.32. Track DMS IMAGING stock price on the chart and check out the list of the most volatile stocks — is DMS IMAGING there?
Today DMS IMAGING has the market capitalization of 30.98 M, it has increased by 33.33% over the last week.
Yes, you can track DMS IMAGING financials in yearly and quarterly reports right on TradingView.
ALIMG net income for the last quarter is −1.43 M EUR, while the quarter before that showed 725.00 K EUR of net income which accounts for −297.79% change. Track more DMS IMAGING financial stats to get the full picture.
No, ALIMG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DMS IMAGING EBITDA is 1.99 M EUR, and current EBITDA margin is 5.28%. See more stats in DMS IMAGING financial statements.
Like other stocks, ALIMG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DMS IMAGING stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DMS IMAGING technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DMS IMAGING stock shows the strong buy signal. See more of DMS IMAGING technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.